Business development with pharmaceutical and biotech companies.
Early stage company activities with venture investors and founders.
Collaborations include companies like Pfizer, Novartis, Merck, Roche and Takeda.
Deals include out-licensing biologics and small molecules, in-licensing marketed drugs, technology licensing, and royalty deals.
Company roadshows and investor relations including most recently Orbimed, Perceptive Investors, Merlin Nexus, Heights Capital, Biotech Value Fund, and NEA.
Banker and analyst activities including Ladenberg, Oppenheimer, Leerink Partners, Roth, Wainwright, Maxim, and Aegis Capital. Total funds raised over $350 million.
World class expert in strategy development, portfolio management and decision analysis at Fortune 500 companies.
Organizational coaching and project consulting based on over 20 years of senior management experience,